RWE Study – Page 7 – Healthcare Data News

May 22, 2022May 23, 2022 Competitor News RWE Study

New Data Presented at DDW 2022 Shows Nearly Two-Fold Risk of Loss of Remission in Ulcerative Colitis Patients who had Histologic Inflammation on Baseline Biopsy

DURHAM, N.C., May 22, 2022 /PRNewswire/ — New data shows that more than a third (36.6%) of ulcerative colitis (UC) patients who have previously responded to advanced therapies experienced a loss of...

New Real-World Evidence Shows ProFound AI Improves Cancer Detection and Accuracy with Digital Breast Tomosynthesis, or 3D Mammography

NASHUA, N.H., May 18, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that new research supporting ProFound AI® for...

May 14, 2022May 16, 2022 Competitor News RWE Study

New Real-World Evidence Shows Improvements in Outcomes and Reduction in Healthcare Costs with Guidance® UTI Precision Diagnostic Test Compared to Standard Urine Culture in Patients with Complicated Urinary Tract Infections

Medicare database analysis presented at the 2022 American Urology Association Meeting found 44% lower total costs and 77% lower clinically-advanced costs with Guidance UTI versus standard urine culture (SUC) IRVINE,...

May 4, 2022May 5, 2022 Competitor News Pharma RWE Study

Pfizer Presents Positive Real-World Evidence for First-Line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer at ESMO Breast Cancer 2022

Wednesday, May 04, 2022 – 07:00am NEW YORK, NY, May 4, 2022 – Pfizer Inc. (NYSE:PFE) announced today the presentation of real-world evidence demonstrating an associated benefit for patients treated...

May 3, 2022May 5, 2022 Collaborations Competitor News Data Partnership RWE Study

Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population

Authors Cheng WY, Sarda SP, Mody-Patel N, Krishnan S, Yenikomshian M, Kunzweiler C, Vu JD, Cheung HC , Duh MS Received 6 November 2021 Accepted for publication 12 April 2022 Published 3 May 2022 Volume 2022:14 Pages 357—369 DOI https://doi.org/10.2147/CEOR.S346816 Checked for plagiarism Yes Review...

April 29, 2022 Industry News Oncology RWE Study

Real-World Data Confirm Lack of Standard Care for Triple-Exposed Multiple Myeloma

Sucharita Mistry, PhD Real-world data confirm that there is no standard approach for treating patients with triple-class-exposed relapsed/refractory multiple myeloma (RRMM), and these patients continue to have poor outcomes. Researchers...

April 29, 2022 Collaborations Competitor News Data Partnership International Middle East RWE Study

Development and Experience with Cancer Risk Prediction Models Using Federated Databases and Electronic Health Records

ABSTRACT Early diagnosis is critical to improving survival rates of lethal cancers, such as pancreatic duct adenocarcinoma (PDAC). However, there are no reliable screening test for these cancers. In this...

April 29, 2022 Competitor News RWE Study

Verana Health to Present Machine Learning and Geographic Atrophy Research at ARVO 2022 Annual Meeting

Research developed using Ophthalmology Qdata™, quality real-world data stemming from the American Academy of Ophthalmology IRIS® Registry SAN FRANCISCO, April 28, 2022 /PRNewswire/ — Verana Health®—a digital health data company elevating quality in...

April 26, 2022April 27, 2022 Competitor News Product Updates RWE Study

Holmusk Announces Publication of Seminal Paper on Real-World Evidence (RWE) Platform NeuroBlu

NEW YORK, April 26, 2022 /PRNewswire/ — Holmusk, a leading global data science and health technology company building the world’s largest real-world evidence (RWE) platform for behavioral health, is pleased to share...

April 22, 2022April 25, 2022 Collaborations Competitor News Data Partnership RWE Study

Verana Health Unveils Annual Ophthalmic Industry Report that Shows a More Than 80% Glaucoma Surgery Uptake Over 8-Year Period

Digital health data company releases the results of its 2021 American Academy of Ophthalmology IRIS® Registry Report at ASCRS 2022 SAN FRANCISCO, April 22, 2022 /PRNewswire/ — Verana Health®—a digital health data company...